Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia

被引:132
|
作者
Prina, Elena [1 ,2 ]
Ranzani, Otavio T. [1 ,2 ]
Polverino, Eva [1 ,3 ]
Cilloniz, Catia [1 ,3 ]
Ferrer, Miquel [1 ,3 ]
Fernandez, Laia [1 ,3 ]
Puig de la Bellacasa, Jorge [4 ]
Menendez, Rosario [3 ,5 ]
Mensa, Josep [6 ]
Torres, Antoni [1 ,3 ]
机构
[1] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, Barcelona, Spain
[2] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst, Sao Paulo, Brazil
[3] Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain
[5] Hosp Univ La Fe, Serv Neumol, Valencia, Spain
[6] Hosp Clin Barcelona, IDIBAPS, Serv Enfermedades Infecciosas, Barcelona, Spain
关键词
community-acquired pneumonia; antibiotic therapy; infection; CARE-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; HOSPITALIZED-PATIENTS; GUIDELINES; DISEASES; SOCIETY; MULTICENTER; INFECTIONS; MANAGEMENT;
D O I
10.1513/AnnalsATS.201407-305OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: To identify pathogens that require different treatments in community-acquired pneumonia (CAP), we propose an acronym, "PES" (Pseudomonas aeruginosa, Enterobacteriaceae extended-spectrum beta-lactamase-positive, and methicillin-resistant Staphylococcus aureus). Objectives: To compare the clinical characteristics and outcomes between patients with CAP caused by PES versus other pathogens, and to identify the risk factors associated with infection caused by PES. Methods: We conducted an observational prospective study evaluating only immunocompetent patients with CAP and an established etiological diagnosis. We included patients from nursing homes. We computed a score to identify patients at risk of PES pathogens. Measurement and Main Results: Of the 4,549 patients evaluated, we analyzed 1,597 who presented an etiological diagnosis. Pneumonia caused by PES was identified in 94 (6%) patients, with 108 PES pathogens isolated (n = 72 P. aeruginosa, n = 15 Enterobacteriaceae extended-spectrum beta-lactamase positive, and n = 21 methicillin-resistant Staphylococcus aureus). These patients were older (P = 0.001), had received prior antibiotic treatment more frequently (P < 0.001), and frequently presented with acute renal failure (P = 0.004). PES pathogens were independently associated with increased risk of 30-day mortality (adjusted odds ratio = 2.51; 95% confidence interval = 1.20-5.25; P = 0.015). The area under the curve for the score we computed was 0.759 (95% confidence interval, 0.713-0.806; P < 0.001). Conclusions: PES pathogens are responsible for a small proportion of CAP, resulting in high mortality. These pathogens require a different antibiotic treatment, and identification of specific risk factors could help to identify these microbial etiologies.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 50 条
  • [31] Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians
    Shindo, Yuichiro
    Hasegawa, Yoshinori
    RESPIROLOGY, 2017, 22 (08) : 1536 - 1546
  • [32] Clinical features and outcome of community-acquired methicillin-resistant Staphylococcus aureus pneumonia
    Obed, Mora
    Garcia-Vidal, Carolina
    Pessacq, Pedro
    Mykietiuk, Analia
    Viasus, Diego
    Cazzola, Laura
    Angeles Dominguez, M.
    Calmaggi, Anibal
    Carratala, Jordi
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (01): : 23 - 27
  • [33] Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia
    Amati, Francesco
    Restrepo, Marcos I.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (04) : 480 - 495
  • [34] Etiology and Factors Contributing to the Severity and Mortality of Community-acquired Pneumonia
    Ishiguro, Takashi
    Takayanagi, Noboru
    Yamaguchi, Shozaburo
    Yamakawa, Hideaki
    Nakamoto, Keitaro
    Takaku, Yotaro
    Miyahara, Yosuke
    Kagiyama, Naho
    Kurashima, Kazuyoshi
    Yanagisawa, Tsutomu
    Sugita, Yutaka
    INTERNAL MEDICINE, 2013, 52 (03) : 317 - 324
  • [35] Advances in antibiotic therapy for community-acquired pneumonia
    Viasus, Diego
    Garcia-Vidal, Carolina
    Carratala, Jordi
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (03) : 209 - 215
  • [36] Duration of Antibiotic Treatment in Community-Acquired Pneumonia
    Uranga Echeverria, Ane
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (12): : 613 - 614
  • [37] Antibiotic treatment outcomes in community-acquired pneumonia
    Cilli, Aykut
    Sayiner, Abdullah
    Celenk, Burcu
    Sakar Coskun, Aysin
    Kilinc, Oguz
    Hazar, Armagan
    Aktas Samur, Anil
    Tasbakan, Sezai
    Waterer, Grant W.
    Havlucu, Yavuz
    Kilic, Oznur
    Tokgoz, Fatma
    Bilge, Ugur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 730 - 736
  • [38] Community-acquired pneumonia
    Welte, T.
    INTERNIST, 2009, 50 (03): : 331 - 339
  • [39] Community-Acquired Pneumonia
    Wunderink, Richard G.
    Waterer, Grant W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06) : 543 - 551
  • [40] Community-acquired pneumonia
    Carbonara, Sergio
    Monno, Laura
    Longo, Benedetta
    Angarano, Gioacchino
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (03) : 261 - 273